Related Experiment Video
Updated: May 15, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Tobacco use during military deployment
G Wayne Talcott1, Jeffrey Cigrang, Deborah Sherrill-Mittleman
1Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. wtalcott@uthsc.edu
Tobacco use remains high among military personnel throughout deployment cycles. Interventions at each stage of deployment may reduce tobacco use initiation, maintenance, and escalation in the U.S. military.
Area of Science:
- Military Health
- Tobacco Control
- Deployment Medicine
Background:
- Tobacco use in military personnel incurs substantial healthcare costs, productivity losses, and impacts combat readiness.
- Prevalence of tobacco use is high and may escalate in high-risk environments like deployment.
Purpose of the Study:
- To assess tobacco use prevalence across the deployment cycle.
- To examine changes in tobacco use patterns during deployment.
- To investigate the influence of deployment history on tobacco use.
Main Methods:
- Evaluated cigarette smoking, smokeless tobacco (ST) use, and dual tobacco use.
- Included 278 U.S. Air Force Security Forces personnel during a 1-year deployment.
- Employed multinomial regression for cross-sectional and longitudinal analysis.
Main Results:
- Over half of personnel used tobacco at all deployment stages (53%-63%).
- Significant differences in initiation/escalation and cessation/reduction rates occurred between predeployment, deployed, and postdeployment phases.
- Prior deployment experience increased likelihood of ST use predeployment and dual tobacco use during deployment.
Conclusions:
- Targeted or universal interventions at each deployment stage could mitigate tobacco use onset, maintenance, or escalation.
- Findings support the need for tailored tobacco cessation programs for military personnel.
- Addressing tobacco use throughout the deployment cycle is crucial for military health and readiness.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Dependence
Stress Prevention and Stress Management Techniques IV
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Other Pulmonary Disorders
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

